Nuo-Beta Pharmaceutical Technology (Shanghai) Co., Ltd.
Patents held now
No granted US patent is recorded under this name. The published applications below are what the record holds.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 1 abandoned
Showing 1 to 4 of 4, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/697,015 | Halogenated Phenylarsine Oxide Compound and Application Thereof | Sep 30, 2022 | Pending |
| 17/995,099 | Deuterated Oxophenylarsine Compound and Use Thereof | Mar 31, 2021 | Pending |
| 17/995,096 | Applications of P14K Inhibitor in Intracellular Protein Misfolding-Related Diseases and Lysosomal Storage Diseases | Mar 31, 2021 | Pending |
| 17/911,103 | Anti-Coronavirus Effect and Application of P14K Inhibitor | Mar 12, 2021 | Abandoned |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built